| A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed Wit | Phase III | rekrutiert |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed | Phase III | rekrutiert |
| A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes | — | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Throm | Phase III | rekrutiert |
| A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapse | Phase III | rekrutiert |
| A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Pati | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associa | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Int | Phase II / Phase III | rekrutiert |
| A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclero | Phase II | rekrutiert |
| A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moder | Phase III | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease | Phase II | rekrutiert |
| A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerativ | Phase II | rekrutiert |
| A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythemato | Phase II | rekrutiert |
| A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseas | Phase III | rekrutiert |
| ARTICE® Real Data Collection & Observational Trial, Phase 4 Study | — | rekrutiert |
| Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell | Phase III | rekrutiert |
| An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Mode | Phase III | rekrutiert |
| An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Mode | Phase III | rekrutiert |
| Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Pat | Phase II | rekrutiert |
| Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke | Phase III | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| Clinical Epidemiology in Contemporary Patients With Myelofibrosis. | — | rekrutiert |
| Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD | Phase III | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| DERIVO® 2heal® Study: Clinical Safety and Efficacy of the DERIVO® 2heal® Embolisation Device | — | rekrutiert |
| Device Global Registry for the IlluminOss Bone Stabilization System | — | rekrutiert |
| Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell | Phase II | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm) | — | rekrutiert |
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors | Phase I / Phase II | rekrutiert |
| IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL | Phase III | rekrutiert |
| Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC | Phase II | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH | Phase III | rekrutiert |
| Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and | Phase III | rekrutiert |
| Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab | Phase II | rekrutiert |
| Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in A | Phase III | rekrutiert |
| PEEP vs. ZEEP in Out-of-Hospital-Cardiac-Arrest | ohne Phasenangabe | rekrutiert |
| Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive | Phase III | rekrutiert |
| Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With New | Phase III | rekrutiert |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - POR | Phase III | rekrutiert |
| Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation | ohne Phasenangabe | rekrutiert |
| Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study | — | rekrutiert |
| Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy | Phase II | rekrutiert |
| Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Ac | — | rekrutiert |
| Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearran | Phase III | rekrutiert |
| Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Ther | Phase II / Phase III | rekrutiert |
| Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participan | Phase III | rekrutiert |
| Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior | — | rekrutiert |
| Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated E | Phase III | rekrutiert |
| Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With | — | rekrutiert |
| Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With P | Phase III | rekrutiert |
| Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-A | Phase III | rekrutiert |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM AL | Phase III | rekrutiert |
| Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metast | Phase II | rekrutiert |